Penwest Pharmaceutical (PPCO) Formulation Demonstrates Proof-of-Principal in Phase I Trial in Development Program With Otsuka Pharmaceutical Co., Ltd.
10/28/2009 8:23:30 AM
More...
|
MethylGene Issues Shares to Otsuka Pharmaceutical Co., Ltd.
10/21/2009 1:24:45 PM
More...
|
MethylGene Announces Equity Investment From Otsuka Pharmaceutical Co., Ltd.
10/15/2009 9:45:52 AM
More...
|
MethylGene and Otsuka Pharmaceutical Co., Ltd. Extend Funded Research Collaboration; Methylgene Could get up to $50.5 Million
9/9/2009 6:53:08 AM
More...
|
Penwest Pharmaceutical (PPCO) Enters Into Third Research and Development Agreement With Otsuka Pharmaceutical Co., Ltd.
6/17/2009 10:02:00 AM
More...
|
Otsuka Pharmaceutical Co., Ltd.: FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
5/22/2009 7:32:08 AM
More...
|
Penwest Pharmaceutical (PPCO) Enters Into Second Research and Development Agreement With Otsuka Pharmaceutical Co., Ltd.
11/25/2008 8:44:41 AM
More...
|
Galenea and Otsuka Pharmaceutical Co., Ltd. Extend & Expand Schizophrenia Research Collaboration Worth $75 Million
10/6/2008 6:50:13 AM
More...
|
Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration
9/8/2008 11:59:15 AM
More...
|
Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye
9/4/2008 6:39:26 AM
More...
|
|